Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by LaserStock29on May 03, 2020 2:06pm
165 Views
Post# 30981257

RE:RE:RE:I Wonder

RE:RE:RE:I Wonder
PeerReviewed wrote: Lets see.  Bunge doesn't belief that Roger putting his own money buying into the market since October has nothing meaningful.

So Roger would do this for no particular reason, not knowing what's coming up?

Bunge knows more than Roger? lolll

Kid Kool-Aid Bunge's logic is always unbeatable!  I'll let him think he's right.  

Bunge's logic is anyways simply driven by a share price.  

Other members have been granted options, like that's the case for any company that is involved in R&D and that doesn't have revenues.

The only variable for the moment that TLT doesn't control is the final decision of the FDA regarding the IND.  By chance, we at least have data from at least 12 patients on the canadian side, with the same technology.


That variable was answered by Theralase in the hiring of Mr.Sharazi who was hired specifically to deal with the FDA in bringing Bladder Cancer to the USA and to market... only that one indication..


There's no AT LEAST

This board said for months if not years that patient data had to be 6 months.. then it was all about the IND and getting into the USA... USA DATA USA DATA...

It's all baloni sandwiches........


Is it a quick flip to .40  or a real inflection point for Longs

and a real summer to enjoy for all.


Yes.. the bulljive of days past of Theralase fumbling paperwork, markings, whatever other garbage excuses.. im really sick and tired of it.


Bullboard Posts